文献速递呼吸道感染呼吸危重症与机械通气

COVID-19四波疫情期间插管时机对患者的影响:一项匹配分析

Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis.
PubMed 文献 · Eur Respir J · 2023-03-02

本研究为多中心前瞻性队列研究的二次分析,纳入58个西班牙ICU中2725例接受有创机械通气的COVID-19患者,经倾向性评分匹配后614例(每组307例)进入分析。结果显示延迟插管(入ICU超过24小时)与更高的住院死亡率(37.1% vs 27.3%,p=0.01)、ICU死亡率(36.1% vs 25.7%,p=0.007)和90天死亡率(40.2% vs 30.9%,p=0.02)相关,且早期插管的使用随疫情波次显著下降。

要点

  • 延迟插管(>24h)与更高的住院、ICU及90天死亡率相关。
  • 早期插管比例随疫情波次下降(72%→49%→46%→45%)。
  • 接受HFNC的患者中,早期插管者住院死亡率更低。

核心结论

  • 在需要IMV的COVID-19患者中,延迟插管与更高的住院死亡风险相关。
  • 早期插管的使用在疫情各波次中显著下降。
  • 早期插管的获益在接受HFNC的患者中更为明显。

研究设计与样本

  • 研究为多中心、观察性、前瞻性队列研究的二次分析。
  • 纳入58个西班牙ICU中2020年2月29日至2021年8月31日期间连续接受IMV的COVID-19患者。
  • 早期插管定义为入ICU后24小时内插管,采用倾向性评分匹配平衡基线变量,并进行了48小时时间点的敏感性分析。

主要发现

  • 共2725例接受IMV,匹配后614例纳入分析(早期组307例,延迟组307例)。
  • 匹配后延迟插管组住院死亡率27.3% vs 37.1%(p=0.01),ICU死亡率25.7% vs 36.1%(p=0.007),90天死亡率30.9% vs 40.2%(p=0.02)。
  • 使用48小时时间点进行敏感性分析观察到非常相似的结果。
  • 早期插管比例在第一至第四波分别为72%、49%、46%、45%(第一波 vs 第二、三、四波 p<0.001)。
  • 接受HFNC(n=294)的患者中,早期插管者住院死亡率更低;接受NIV(n=214)的患者中,以48小时定义延迟插管时死亡率更高,以24小时定义时无此差异。

关键数值与推荐

  • 早期插管定义为入ICU后24小时内插管。
  • 敏感性分析采用入ICU后48小时作为早期与延迟插管的时间点。

临床怎么用

  • 对于COVID-19相关呼吸衰竭需要IMV的患者,应考虑及时插管以避免延迟。
  • 接受HFNC治疗的患者若病情恶化,早期插管可能获益更明显。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The primary aim of our study was to investigate the association between intubation timing and hospital mortality in critically ill patients with coronavirus disease 2019 (COVID-19)-associated respiratory failure. We also analysed both the impact of such timing throughout the first four pandemic waves and the influence of prior noninvasive respiratory support on outcomes. METHODS: This is a secondary analysis of a multicentre, observational and prospective cohort study that included all consecutive patients undergoing invasive mechanical ventilation due to COVID-19 from across 58 Spanish intensive care units (ICUs) participating in the CIBERESUCICOVID project. The study period was between 29 February 2020 and 31 August 2021. Early intubation was defined as that occurring within the first 24 h of ICU admission. Propensity score matching was used to achieve a balance across baseline variables between the early intubation cohort and those patients who were intubated after the first 24 h of ICU admission. Differences in outcomes between early and delayed intubation were also assessed. We performed sensitivity analyses to consider a different time-point (48 h from ICU admission) for early and delayed intubation. RESULTS: Of the 2725 patients who received invasive mechanical ventilation, a total of 614 matched patients were included in the analysis (307 for each group). In the unmatched population, there were no differences in mortality between the early and delayed groups. After propensity score matching, patients with delayed intubation presented higher hospital mortality (27.3% versus 37.1%; p=0.01), ICU mortality (25.7% versus 36.1%; p=0.007) and 90-day mortality (30.9% versus 40.2%; p=0.02) compared with the early intubation group. Very similar findings were observed when we used a 48-h time-point for early or delayed intubation. The use of early intubation decreased after the first wave of the pandemic (72%, 49%, 46% and 45% in the first, second, third and fourth waves, respectively; first versus second, third and fourth waves p<0.001). In both the main and sensitivity analyses, hospital mortality was lower in patients receiving high-flow nasal cannula (HFNC) (n=294) who were intubated earlier. The subgroup of patients undergoing noninvasive ventilation (n=214) before intubation showed higher mortality when delayed intubation was set as that occurring after 48 h from ICU admission, but not when after 24 h. CONCLUSIONS: In patients with COVID-19 requiring invasive mechanical ventilation, delayed intubation was associated with a higher risk of hospital mortality. The use of early intubation significantly decreased throughout the course of the pandemic. Benefits of such an approach occurred more notably in patients who had received HFNC.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Riera J, Barbeta E, Tormos A, et al. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis. Eur Respir J. 2023. PMID: 36396142. doi:10.1183/13993003.01426-2022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。